1-deoxynojirimycin has been researched along with Benign Neoplasms, Brain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bieberich, E; Freischütz, B; Suzuki, M; Yu, RK | 1 |
| El-Abbadi, M; Manfredi, MG; Mukherjee, P; Platt, FM; Ranes, MK; Seyfried, TN | 1 |
2 other study(ies) available for 1-deoxynojirimycin and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Differential effects of glycolipid biosynthesis inhibitors on ceramide-induced cell death in neuroblastoma cells.
Topics: 1-Deoxynojirimycin; Animals; Apoptosis; Brain Neoplasms; Cell Death; Cell Division; Ceramides; Enzyme Inhibitors; Gaucher Disease; Glucosylceramides; Glucosyltransferases; Glycolipids; Mice; Morpholines; Neuroblastoma; Rats; Tumor Cells, Cultured | 1999 |
N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours.
Topics: 1-Deoxynojirimycin; Animals; Body Weight; Brain; Brain Neoplasms; Cell Count; Cell Division; Gangliosides; Intestines; Liver; Male; Methylcholanthrene; Mice; Mice, Inbred C57BL; Time Factors; Tissue Distribution; Tumor Cells, Cultured | 2001 |